Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy
Top Cited Papers
- 28 March 2016
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 113 (15), 4164-4169
- https://doi.org/10.1073/pnas.1522080113
Abstract
A principal goal of cancer nanomedicine is to deliver therapeutics effectively to cancer cells within solid tumors. However, there are a series of biological barriers that impede nanomedicine from reaching target cells. Here, we report a stimuli-responsive clustered nanoparticle to systematically overcome these multiple barriers by sequentially responding to the endogenous attributes of the tumor microenvironment. The smart polymeric clustered nanoparticle (iCluster) has an initial size of ∼100 nm, which is favorable for long blood circulation and high propensity of extravasation through tumor vascular fenestrations. Once iCluster accumulates at tumor sites, the intrinsic tumor extracellular acidity would trigger the discharge of platinum prodrug-conjugated poly(amidoamine) dendrimers (diameter ∼5 nm). Such a structural alteration greatly facilitates tumor penetration and cell internalization of the therapeutics. The internalized dendrimer prodrugs are further reduced intracellularly to release cisplatin to kill cancer cells. The superior in vivo antitumor activities of iCluster are validated in varying intractable tumor models including poorly permeable pancreatic cancer, drug-resistant cancer, and metastatic cancer, demonstrating its versatility and broad applicability.Keywords
Funding Information
- National Basic Research Program of China (2012CB932500, 2015CB932100 and 2013CB933900)
- National Natural Science Foundation of China (51125012, 51390482)
- National Natural Science Foundation of China (51503195)
This publication has 48 references indexed in Scilit:
- Principles of nanoparticle design for overcoming biological barriers to drug deliveryNature Biotechnology, 2015
- Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin releaseBiomaterials, 2015
- A nanoparticle-based strategy for the imaging of a broad range of tumours by nonlinear amplification of microenvironment signalsNature Materials, 2013
- A Nanoparticle Size Series for In Vivo Fluorescence ImagingAngewandte Chemie-International Edition, 2010
- Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) WarheadsJournal of the American Chemical Society, 2009
- Nanoparticle therapeutics: an emerging treatment modality for cancerNature Reviews Drug Discovery, 2008
- The effect of particle design on cellular internalization pathwaysProceedings of the National Academy of Sciences of the United States of America, 2008
- Nanocarriers as an emerging platform for cancer therapyNature Nanotechnology, 2007
- Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlationNature Medicine, 1997
- A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs.1986